İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
Philip Morris International Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $284.5B | |
|---|---|---|
| Revenue (ttm) | 43.1B | |
| Net income (ttm) | 10.7B | |
| EPS (ttm) | $6.85 | |
| Shares out | 1.6B | |
| P/E (trailing) | 29.6x | |
| P/E (forward) | 20.4x | |
| Dividend | $6.40 (3.16%) | |
| Volume | 2,235,197 | |
| Beta | 0.36 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $31.41B | $31.76B | $35.17B | $37.88B | $40.65B | +6.7% |
| Gross profit | $21.38B | $20.36B | $22.28B | $24.55B | $27.28B | +6.3% |
| Operating income | $12.98B | $12.25B | $11.56B | $13.40B | $14.89B | +3.5% |
| Net income | $9.11B | $9.05B | $7.81B | $7.06B | $11.35B | +5.6% |
| EPS (diluted) | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 | +5.6% |
| EBITDA | $2.93B | $13.48B | $13.37B | $15.75B | $17.46B | +56.3% |
| R&D | $617.0M | $642.0M | $709.0M | $759.0M | $756.0M | +5.2% |
| SG&A | $8.42B | $8.11B | $10.06B | $11.15B | $11.75B | +8.7% |
Recent company headlines from major financial publishers.
The base path requires FY2027 revenue and adjusted EPS near analyst forecasts as of 2026-09-09. Each annual update should test whether Europe revenue growth remains positive and reported profit keeps turning into operating cash. Europe stagnation or weaker cash generation would disconfirm the path.
The path gains support if FY2027 revenue and adjusted EPS exceed dated expectations while free cash flow remains strong. Positive Europe growth must also continue; Europe stagnation would disconfirm the path.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 5.6% | $285 | $324 | $392 | $559 | $587 |
| 6.4% | $244 | $265 | $296 | $346 | $447 |
| 7.1% | $217 | $230 | $249 | $273 | $311 |
| 7.8% | $199 | $207 | $219 | $233 | $254 |
| 8.5% | $185 | $191 | $199 | $208 | $221 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |